• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱内支架位置是相关发病率的预测指标吗?

Is intravesical stent position a predictor of associated morbidity?

作者信息

Abt Dominik, Mordasini Livio, Warzinek Elisabeth, Schmid Hans-Peter, Haile Sarah Roberta, Engeler Daniel Stephan, Müllhaupt Gautier

机构信息

Department of Urology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.

Clinical Trials Unit, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.

出版信息

Korean J Urol. 2015 May;56(5):370-8. doi: 10.4111/kju.2015.56.5.370. Epub 2015 Apr 24.

DOI:10.4111/kju.2015.56.5.370
PMID:25964838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4426509/
Abstract

PURPOSE

Temporary drainage of the upper urinary tract by use of internal ureteral stents is a common procedure that is often associated with a variety of symptoms. The role of intravesical stent position in associated morbidity is controversial.

MATERIALS AND METHODS

The German version of the ureteral stent symptom questionnaire (USSQ) was completed by 73 patients with an indwelling ureteral stent the day before stent removal. Intravesical stent position was classified into 3 categories by x-ray before stent removal. The influence of intravesical stent position on USSQ score was analyzed, including subscores and single items.

RESULTS

Intravesical stent position showed no significant influence on associated morbidity. The median USSQ total score in all patients was 77.5 (range, 30-147). Patients with ipsilateral stents (69.0; range, 30-122) tended to have lower total scores than did those with tangential (86.5; range, 30-122) or contralateral (77.0; range, 31-147) stents, but the differences were not statistically significant (p=0.35). The USSQ subscores for urinary symptoms (p=0.80), body pain (p=0.80), general health (p=0.16), work performance (p=0.07), additional problems (p=0.81), and all of the USSQ single items of interest in the context of stent length also did not differ significantly between the three groups.

CONCLUSIONS

Intravesical stent position did not significantly influence associated morbidity in our study. An appropriate stent length should be chosen to avoid dislocation. However, complex calculations of optimum stent length, time-consuming manipulations, and costly stock holding of various stent sizes to obtain the perfect stent position do not seem worthwhile.

摘要

目的

使用输尿管内支架对上尿路进行临时引流是一种常见的操作,常伴有多种症状。膀胱内支架位置在相关发病率中的作用存在争议。

材料与方法

73例留置输尿管支架的患者在支架取出前一天完成了输尿管支架症状问卷(USSQ)德文版。在支架取出前通过X线将膀胱内支架位置分为3类。分析膀胱内支架位置对USSQ评分的影响,包括子评分和单项评分。

结果

膀胱内支架位置对相关发病率无显著影响。所有患者的USSQ总评分中位数为77.5(范围30 - 147)。同侧支架患者(69.0;范围30 - 122)的总评分往往低于切线位(86.5;范围30 - 122)或对侧(77.0;范围31 - 147)支架患者,但差异无统计学意义(p = 0.35)。三组间在泌尿症状(p = 0.80)、身体疼痛(p = 0.80)、总体健康(p = 0.16)、工作表现(p = 0.07)、其他问题(p = 0.81)的USSQ子评分以及在支架长度方面所有感兴趣的USSQ单项评分也无显著差异。

结论

在我们的研究中,膀胱内支架位置对相关发病率无显著影响。应选择合适的支架长度以避免移位。然而,为获得理想的支架位置而进行复杂的最佳支架长度计算、耗时的操作以及储存各种支架尺寸的高昂成本似乎并不值得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fa/4426509/3ae465180452/kju-56-370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fa/4426509/55a1dba493ef/kju-56-370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fa/4426509/3ae465180452/kju-56-370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fa/4426509/55a1dba493ef/kju-56-370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fa/4426509/3ae465180452/kju-56-370-g002.jpg

相似文献

1
Is intravesical stent position a predictor of associated morbidity?膀胱内支架位置是相关发病率的预测指标吗?
Korean J Urol. 2015 May;56(5):370-8. doi: 10.4111/kju.2015.56.5.370. Epub 2015 Apr 24.
2
Influence of patient education on morbidity caused by ureteral stents.患者教育对输尿管支架所致发病率的影响。
Int J Urol. 2015 Jul;22(7):679-83. doi: 10.1111/iju.12782. Epub 2015 Apr 16.
3
Intravesical stent position as a predictor of quality of life in patients with indwelling ureteral stent.留置输尿管支架患者的膀胱内支架位置与生活质量的关系。
Int Urol Nephrol. 2019 Nov;51(11):1949-1953. doi: 10.1007/s11255-019-02262-7. Epub 2019 Aug 22.
4
Reduction of stent-associated morbidity by minimizing stent material: a prospective, randomized, single-blind superiority trial assessing a customized 'suture stent'.通过最小化支架材料减少支架相关并发症:一项前瞻性、随机、单盲优效性试验,评估一种定制的“缝合支架”。
BJU Int. 2021 May;127(5):596-605. doi: 10.1111/bju.15290. Epub 2020 Dec 15.
5
The German linguistic validation of the Ureteral Stent Symptoms Questionnaire (USSQ).输尿管支架症状问卷(USSQ)的德语语言验证。
World J Urol. 2017 Mar;35(3):443-447. doi: 10.1007/s00345-016-1875-6. Epub 2016 Jun 23.
6
Multi-length or 24 cm ureteric stent? A multicentre randomised comparison of stent-related symptoms using a validated questionnaire.多长度或 24 厘米输尿管支架?使用经过验证的问卷对支架相关症状进行的多中心随机比较。
BJU Int. 2013 Jun;111(7):1099-104. doi: 10.1111/j.1464-410X.2012.11388.x. Epub 2012 Aug 9.
7
Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial.与单独使用坦索罗辛相比,坦索罗辛与托特罗定联合治疗能否改善输尿管支架不适?一项双盲、随机、对照试验。
J Urol. 2016 Feb;195(2):385-90. doi: 10.1016/j.juro.2015.08.104. Epub 2015 Sep 21.
8
The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial.普瑞巴林在缓解输尿管支架相关症状中的作用:一项随机对照临床试验。
Int Urol Nephrol. 2017 Jun;49(6):961-966. doi: 10.1007/s11255-017-1561-7. Epub 2017 Mar 4.
9
The impact of ureteral stent type on patient symptoms as determined by the ureteral stent symptom questionnaire: a prospective, randomized, controlled study.输尿管支架症状问卷确定的输尿管支架类型对患者症状的影响:一项前瞻性、随机、对照研究。
J Endourol. 2015 Mar;29(3):367-71. doi: 10.1089/end.2014.0294. Epub 2014 Oct 9.
10
Indwelling ureteral stents: evaluation of symptoms, quality of life and utility.留置输尿管支架:症状、生活质量及效用评估
J Urol. 2003 Mar;169(3):1065-9; discussion 1069. doi: 10.1097/01.ju.0000048980.33855.90.

引用本文的文献

1
Foley catheter after ureteroscopy and JJ stent placement: a randomised prospective European Association of Urology Section of Urolithiasis-Young Academic Urologists (EULIS-YAU) endourology study.输尿管镜检查和置入 JJ 支架后留置 Foley 导尿管:一项由欧洲泌尿外科学会尿石症分会-青年学术泌尿外科医生(EULIS-YAU)进行的随机前瞻性腔内泌尿外科研究。
BJU Int. 2025 Jan;135(1):95-102. doi: 10.1111/bju.16504. Epub 2024 Aug 11.
2
Ureteral stents: A brief narrative review of the different polymeric types, their characteristics, and their connection to stent-related symptoms.输尿管支架:对不同聚合物类型、其特性及其与支架相关症状的联系的简要叙述性综述。
Urol Ann. 2023 Oct-Dec;15(4):360-367. doi: 10.4103/ua.ua_39_23. Epub 2023 Oct 20.
3

本文引用的文献

1
The Spanish linguistic validation of the ureteral stent symptom questionnaire.输尿管支架症状问卷的西班牙语语言验证。
J Endourol. 2014 Feb;28(2):237-42. doi: 10.1089/end.2013.0325. Epub 2013 Nov 9.
2
Multi-length or 24 cm ureteric stent? A multicentre randomised comparison of stent-related symptoms using a validated questionnaire.多长度或 24 厘米输尿管支架?使用经过验证的问卷对支架相关症状进行的多中心随机比较。
BJU Int. 2013 Jun;111(7):1099-104. doi: 10.1111/j.1464-410X.2012.11388.x. Epub 2012 Aug 9.
3
Cross-cultural application of the Korean version of Ureteral Stent Symptoms Questionnaire.
Distal end of Double-J ureteral stent position on ureteral stent-related symptoms: A systematic review and meta-analysis.
双J输尿管支架远端位置与输尿管支架相关症状的关系:一项系统评价和荟萃分析。
Front Surg. 2022 Aug 12;9:990049. doi: 10.3389/fsurg.2022.990049. eCollection 2022.
4
Effect of Ureteral Stent Length and Position of Stent Coil in Bladder on Stent-Related Symptoms and Quality of Life of Patients.输尿管支架长度及支架膀胱端线圈位置对患者支架相关症状及生活质量的影响
Cureus. 2020 Nov 24;12(11):e11669. doi: 10.7759/cureus.11669.
5
Challenges To Attenuate Ureteric Stent-Related Symptoms: Reflections On The Need To Fashion A New Dynamic Stent Design Consequent Upon A Case Report.减轻输尿管支架相关症状的挑战:基于一例病例报告对新型动态支架设计必要性的思考
Res Rep Urol. 2019 Oct 23;11:277-281. doi: 10.2147/RRU.S224068. eCollection 2019.
6
Intravesical stent position as a predictor of quality of life in patients with indwelling ureteral stent.留置输尿管支架患者的膀胱内支架位置与生活质量的关系。
Int Urol Nephrol. 2019 Nov;51(11):1949-1953. doi: 10.1007/s11255-019-02262-7. Epub 2019 Aug 22.
7
Role of phosphodiesterase inhibitors in stent-related symptoms: a systematic review and meta-analysis.磷酸二酯酶抑制剂在支架相关症状中的作用:系统评价和荟萃分析。
World J Urol. 2020 Apr;38(4):929-938. doi: 10.1007/s00345-019-02862-z. Epub 2019 Jun 28.
8
Influence of biofilms on morbidity associated with short-term indwelling ureteral stents: a prospective observational study.生物膜对短期留置输尿管支架相关发病率的影响:一项前瞻性观察研究。
World J Urol. 2019 Aug;37(8):1703-1711. doi: 10.1007/s00345-018-2569-z. Epub 2018 Nov 27.
9
Ureteral Stent Discomfort and Its Management.输尿管支架不适及其处理
Curr Urol Rep. 2018 Jun 11;19(8):64. doi: 10.1007/s11934-018-0818-8.
10
A ureteral stent crossing the bladder midline leads to worse urinary symptoms.一根穿过膀胱中线的输尿管支架会导致更严重的泌尿系统症状。
Cent European J Urol. 2017;70(4):412-417. doi: 10.5173/ceju.2017.1533. Epub 2017 Nov 7.
《输尿管支架症状问卷》韩文版的跨文化应用。
J Endourol. 2012 Nov;26(11):1518-22. doi: 10.1089/end.2012.0235. Epub 2012 Sep 17.
4
Initial experience with a newly developed antirefluxive ureter stent.新型抗反流输尿管支架的初步经验
Urol Res. 2012 Aug;40(4):349-53. doi: 10.1007/s00240-011-0415-5. Epub 2011 Aug 18.
5
Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort.荟萃分析显示 α 受体阻滞剂对输尿管支架不适的有益作用。
BJU Int. 2011 Dec;108(11):1894-902. doi: 10.1111/j.1464-410X.2011.10170.x. Epub 2011 Mar 31.
6
Relief of stent related symptoms: review of engineering and pharmacological solutions.支架相关症状的缓解:工程学和药理学解决方案综述。
J Urol. 2010 Oct;184(4):1267-72. doi: 10.1016/j.juro.2010.06.043. Epub 2010 Aug 17.
7
Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire.留置输尿管支架患者发病率的预测因素:使用经过验证的输尿管支架症状问卷进行的前瞻性研究结果。
BJU Int. 2011 Feb;107(4):648-54. doi: 10.1111/j.1464-410X.2010.09482.x.
8
[The French linguistic validation of the Ureteric Stent Symptom Questionnaire (USSQ)].[输尿管支架症状问卷(USSQ)的法语语言验证]
Prog Urol. 2010 Mar;20(3):210-3. doi: 10.1016/j.purol.2009.09.007. Epub 2009 Oct 29.
9
A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent.一种新型药物洗脱输尿管支架:一项前瞻性、随机、多中心临床试验,旨在评估载有酮咯酸的输尿管支架的安全性和有效性。
J Urol. 2010 Mar;183(3):1037-42. doi: 10.1016/j.juro.2009.11.035. Epub 2010 Jan 21.
10
The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms.托特罗定缓释剂和阿夫唑嗪治疗双 J 支架相关症状的效果。
J Endourol. 2009 Nov;23(11):1913-7. doi: 10.1089/end.2009.0173.